![Cancers | Free Full-Text | Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases Cancers | Free Full-Text | Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases](https://pub.mdpi-res.com/cancers/cancers-14-04385/article_deploy/html/images/cancers-14-04385-g001.png?1662701546)
Cancers | Free Full-Text | Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases
![Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents - The Lancet Infectious Diseases Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/d14352a6-cac4-49c1-a296-4fe22d19c5e9/gr1_lrg.jpg)
Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents - The Lancet Infectious Diseases
![Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study - The Lancet Rheumatology Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study - The Lancet Rheumatology](https://www.thelancet.com/cms/attachment/631cbb4c-6b66-489c-9fc4-145ae80b5bcb/gr1.gif)
Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study - The Lancet Rheumatology
![Frontiers | Drugs for the prevention and treatment of COVID-19 and its complications: An update on what we learned in the past 2 years Frontiers | Drugs for the prevention and treatment of COVID-19 and its complications: An update on what we learned in the past 2 years](https://www.frontiersin.org/files/MyHome%20Article%20Library/987816/987816_Thumb_400.jpg)
Frontiers | Drugs for the prevention and treatment of COVID-19 and its complications: An update on what we learned in the past 2 years
![Frontiers | Efficacy and safety profile of corticosteroids and non-steroidal anti-inflammatory drugs in COVID-19 management: A narrative review Frontiers | Efficacy and safety profile of corticosteroids and non-steroidal anti-inflammatory drugs in COVID-19 management: A narrative review](https://www.frontiersin.org/files/MyHome%20Article%20Library/1063246/1063246_Thumb_400.jpg)
Frontiers | Efficacy and safety profile of corticosteroids and non-steroidal anti-inflammatory drugs in COVID-19 management: A narrative review
![Medicina | Free Full-Text | Is Antioxidant Therapy a Useful Complementary Measure for Covid-19 Treatment? An Algorithm for Its Application Medicina | Free Full-Text | Is Antioxidant Therapy a Useful Complementary Measure for Covid-19 Treatment? An Algorithm for Its Application](https://pub.mdpi-res.com/medicina/medicina-56-00386/article_deploy/html/images/medicina-56-00386-ag-550.jpg?1616056238)
Medicina | Free Full-Text | Is Antioxidant Therapy a Useful Complementary Measure for Covid-19 Treatment? An Algorithm for Its Application
![BioMed | Free Full-Text | Early Multi-Target Treatment of Mild-to-Moderate COVID-19, Particularly in Terms of Non-Steroidal Anti-Inflammatory Drugs and Indomethacin BioMed | Free Full-Text | Early Multi-Target Treatment of Mild-to-Moderate COVID-19, Particularly in Terms of Non-Steroidal Anti-Inflammatory Drugs and Indomethacin](https://pub.mdpi-res.com/biomed/biomed-03-00015/article_deploy/html/images/biomed-03-00015-g001.png?1678450543)
BioMed | Free Full-Text | Early Multi-Target Treatment of Mild-to-Moderate COVID-19, Particularly in Terms of Non-Steroidal Anti-Inflammatory Drugs and Indomethacin
![Early use of non-steroidal anti-inflammatory drugs in COVID-19 might reverse pathogenesis, prevent complications and improve clinical outcomes - ScienceDirect Early use of non-steroidal anti-inflammatory drugs in COVID-19 might reverse pathogenesis, prevent complications and improve clinical outcomes - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332220311744-ga1.jpg)
Early use of non-steroidal anti-inflammatory drugs in COVID-19 might reverse pathogenesis, prevent complications and improve clinical outcomes - ScienceDirect
![Frontiers | Effect of the chronic medication use on outcome measures of hospitalized COVID-19 patients: Evidence from big data Frontiers | Effect of the chronic medication use on outcome measures of hospitalized COVID-19 patients: Evidence from big data](https://www.frontiersin.org/files/Articles/1061307/fpubh-11-1061307-HTML/image_m/fpubh-11-1061307-g001.jpg)
Frontiers | Effect of the chronic medication use on outcome measures of hospitalized COVID-19 patients: Evidence from big data
![Non-steroidal anti-inflammatory drugs in the era of the Covid-19 pandemic in the context of the human and the environment - ScienceDirect Non-steroidal anti-inflammatory drugs in the era of the Covid-19 pandemic in the context of the human and the environment - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S004896972202410X-ga1.jpg)
Non-steroidal anti-inflammatory drugs in the era of the Covid-19 pandemic in the context of the human and the environment - ScienceDirect
![Dentistry Journal | Free Full-Text | Loxoprofen Sodium Versus Diclofenac Potassium for Post-Dental Extraction Pain Relief: A Randomized, Triple-Blind, Clinical Trial Dentistry Journal | Free Full-Text | Loxoprofen Sodium Versus Diclofenac Potassium for Post-Dental Extraction Pain Relief: A Randomized, Triple-Blind, Clinical Trial](https://www.mdpi.com/dentistry/dentistry-08-00002/article_deploy/html/images/dentistry-08-00002-g001.png)
Dentistry Journal | Free Full-Text | Loxoprofen Sodium Versus Diclofenac Potassium for Post-Dental Extraction Pain Relief: A Randomized, Triple-Blind, Clinical Trial
![Cardiovascular and Bleeding Risks Associated With Nonsteroidal Anti-Inflammatory Drugs After Myocardial Infarction | Journal of the American College of Cardiology Cardiovascular and Bleeding Risks Associated With Nonsteroidal Anti-Inflammatory Drugs After Myocardial Infarction | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/0174af37-6db2-4b29-924c-843fcdc2712f/fx1.jpg)
Cardiovascular and Bleeding Risks Associated With Nonsteroidal Anti-Inflammatory Drugs After Myocardial Infarction | Journal of the American College of Cardiology
![Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial - The Lancet Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial - The Lancet](https://www.thelancet.com/cms/attachment/2001011244/2003796220/gr1.gif)
Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial - The Lancet
![BioMed | Free Full-Text | Early Multi-Target Treatment of Mild-to-Moderate COVID-19, Particularly in Terms of Non-Steroidal Anti-Inflammatory Drugs and Indomethacin BioMed | Free Full-Text | Early Multi-Target Treatment of Mild-to-Moderate COVID-19, Particularly in Terms of Non-Steroidal Anti-Inflammatory Drugs and Indomethacin](https://pub.mdpi-res.com/biomed/biomed-03-00015/article_deploy/html/images/biomed-03-00015-ag-550.jpg?1678691991)
BioMed | Free Full-Text | Early Multi-Target Treatment of Mild-to-Moderate COVID-19, Particularly in Terms of Non-Steroidal Anti-Inflammatory Drugs and Indomethacin
![Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis | The BMJ Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis | The BMJ](https://www.bmj.com/content/bmj/375/bmj.n2321/F2.medium.jpg)
Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis | The BMJ
![NSAID use and clinical outcomes in COVID-19 patients: a 38-center retrospective cohort study | Virology Journal | Full Text NSAID use and clinical outcomes in COVID-19 patients: a 38-center retrospective cohort study | Virology Journal | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12985-022-01813-2/MediaObjects/12985_2022_1813_Fig1_HTML.png)
NSAID use and clinical outcomes in COVID-19 patients: a 38-center retrospective cohort study | Virology Journal | Full Text
![Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study - The Lancet Rheumatology Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study - The Lancet Rheumatology](https://www.thelancet.com/cms/asset/5e0eb0f1-3156-4d98-95cc-e3597a4254d3/gr2.jpg)